Top news of the week: 05.10.2022.
The Top 5 Genome Sequencing Companies by Revenue
The gene sequencing industry has really taken off in the years since the Human Genome Project. Look at these best genome sequencing companies in the world.
Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis
Dupixent has received regulatory approvals in one or more countries around the world for use in certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal …
M&A Frenzy: Incyte & Villaris, AmplifyBio & PACT, Estrella Earns Nasdaq Listing (Updated)
Incyte Corporation will acquire privately-held Villaris, AmplifyBio will acquire PACT Pharma, while Estrella will gain a spot on the Nasdaq Exchange.
The biotech scorecard for the fourth quarter: 14 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter.
Organoids With Vascularization and Immune Cells Launched by AIM Biotech
AIM Biotech launched organiX, a new system to model human disease by combining organoids, perfusable vasculature, and immune-competence.
Carolyn Bertozzi, repeat biotech founder and launcher of a field, shares in chemistry Nobel win
Carolyn Bertozzi, predicted by some to become a Nobel laureate, clinched one of the world's top awards in the wee hours of Wednesday, winning the Nobel Prize in Chemistry alongside a repeat ...
Ginkgo Strengthens Cell and Gene Therapy Services with Circularis, Altar (Updated)
Ginkgo Bioworks opened its wallet Tuesday and snapped up Circularis and Altar to strengthen its cell and gene therapy programs and bolster its manufacturing capabilities.
Cell and Gene Therapy Manufacturing and Commercialization US 2022 – Impressions of this year’s event
Informa Connect just concluded its Cell & Gene Therapy Manufacturing and Commercialization US event (CGT 2022). As part of Biotech Week Boston, a